Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis

Circulation

Volumn 120, Issue 23, 2009, Pages 2367-2376

  Maurer, Britta ^a   Busch, Nicole ^b   Jüngel, Astrid ^a   Pileckyte, Margarita ^c   Gay, Renate E ^a   Michel, Beat A ^a   Schett, Georg ^a   Gay, Steffen ^b   Distler, Jörg ^b   Distler, Oliver ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c KAUNAS UNIVERSITY OF MEDICINE HOSPITAL   (Lithuania)

Author keywords

Endothelial cells; Peripheral vascular diseases; Systemic sclerosis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; PROTEIN FOS; SMALL INTERFERING RNA; STAUROSPORINE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 2; TRANSGELIN; VASCULOTROPIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CAPILLARY DENSITY; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ENDOTHELIUM CELL; FEMALE; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROANGIOPATHY; MICROVASCULARIZATION; MOUSE; NONHUMAN; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BIOPSY; SKIN FIBROSIS; SYSTEMIC SCLEROSIS; TRANSGENIC MOUSE; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; CELL MIGRATION INHIBITION; CELL MOVEMENT; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; FOS-RELATED ANTIGEN-2; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MICE, TRANSGENIC; PERIPHERAL VASCULAR DISEASES; SCLERODERMA, SYSTEMIC;

EID: 73449115656     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.855114     Document Type: Article

References (26)

1. Abraham D, Distler O. How does endothelial cell injury start? The role of endothelin in systemic sclerosis. Arthritis Res Ther. 2007;9(suppl 2):S2.
2. Distler JH, Kalden J, Gay S, Distler O. Vascular changes in the patho-genesis of systemic sclerosis. Z Rheumatol. 2004;63:446-450.
3. Steen VD, Medsger T. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis. 2007;66:940-944.
4. Nihtyanova SI, Brough G, Black CM, Denton CP. Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis. 2008;67:120-123.
5. Sgonc R, Grulich M, Dietrich H, Recheis H, Gershwin ME, Wick G. Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest. 1996;3:785-792.
6. Eferl R, Wagner E. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer. 2003;3:859-868.
7. Foletta VC. Transcription factor AP-1, and the role of Fra-2. Immunol Cell Biol. 1996;74:121-133.
8. Bozec ABL, Hoebertz A, Eferl R, Schilling AF, Komnenovic V, Scheuch H, Priemel M, Stewart CL, Amling M, Wagner EF. Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia. Nature. 2008;454:221-225.
9. Eferl R, Hasselblatt P, Rath M, Popper H, Zenz R, Komnenovic V, Idarraga MH, Kenner L, Wagner EF. Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1. Proc Natl Acad Sci U S A. 2008;105:10525-10530.
10. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15:202-205.
11. Distler JH, Jüngel A, Huber LC, Schulze-Horsel U, Zwerina J, Gay RE, Michel BA, Hauser T, Schett G, Gay S, Distler O. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Arthritis Rheum. 2007;56:311-322.
12. Jüngel A, Distler O, Schulze-Horsel U, Huber LC, Ha HR, Simmen B, Kalden JR, Pisetsky DS, Gay S, Distler JH. Microparticles stimulate the synthesis of prostaglandin E(2) via induction of cyclooxygenase 2 and microsomal prostaglandin E synthase 1. Arthritis Rheum. 2007;56: 3564-3574.
13. Distler JH, Jüngel A, Kowal-Bielecka O, Michel BA, Gay RE, Sprott H, Matucci-Cerinic M, Chilla M, Reich K, Kalden JR, Müller-Ladner U, Lorenz HM, Gay S, Distler O. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis. Arthritis Rheum. 2005; 52:856-864.
14. Andrews NC, Faller D. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 1991;19:2499.
15. Distler JH, Huber L, Hueber AJ, Reich CF III, Gay S, Distler O, Pisetsky DS. The release of microparticles by apoptotic cells and their effects on macrophages. Proc Natl Acad Sci U S A. 2005;10:731-741.
16. Petersen EJ, Miyoshi T, Yuan Z, Hirohata S, Li JZ, Shi W, Angle JF. siRNA silencing reveals role of vascular cell adhesion molecule-1 in vascular smooth muscle cell migration. Atherosclerosis. 2008;198:301-306.
17. Suarez Y, Fernandez-Hernando C, Pober JS, Sessa WC. Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res. 2007;100:1164-1173.
18. Guiducci S, Distler O, Distler JH, Matucci-Cerinic M. Mechanisms of vascular damage in SSc: implications for vascular treatment strategies. Rheumatology. 2008;47(suppl 5):v18-v20.
19. Koch AE, Distler O. Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis. Arthritis Res Ther. 2007;9(suppl 2):S3.
20. Walker UA, Tyndall A, Czirják L, Denton C, Farge-Bancel D, Kowal-Bielecka O, Müller-Ladner U, Bocelli-Tyndall C, Matucci-Cerinic M. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research Database. Ann Rheum Dis. 2007;66:754-763.
21. Abraham DJ, Varga J. Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol. 2005;26:587-595.
22. Sgonc R, Dietrich H, Sieberer C, Wick G, Christner PJ, Jiménez SA. Lack of endothelial cell apoptosis in the skin of tight skin 1 and tight skin 2 mice. Arthritis Rheum. 1999;42:581-584.
23. McHenry JZ, Leon A, Matthaei KI, Cohen DR. Overexpression of Fra-2 in transgenic mice perturbs normal eye development. Oncogene. 1998; 17:1131-1140.
24. Tulchinsky E. Fos family members: regulation, structure and role in oncogenic transformation. Histol Histopathol. 2000;15:921-928.
25. van Dam H, Castellazi M. Distinct roles of Jun:Fos and Jun:ATF dimers in oncogenesis. Oncogene. 2001;20:2453-2464.
26. Zoumpourlis V, Papassava P, Linardopoulos S, Gillespie D, Balmain A, Pintzas A. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model. Oncogene. 2000;19:4011-4021.